|
GSG2 expression based on
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.331600E-02 |
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.493950E-01 |
| Normal-vs-Stage2 |
4.455500E-03 |
| Normal-vs-Stage3 |
5.879900E-02 |
| Normal-vs-Stage4 |
5.312400E-02 |
| Stage1-vs-Stage2 |
1.61560000000449E-06 |
| Stage1-vs-Stage3 |
1.795790E-01 |
| Stage1-vs-Stage4 |
1.863950E-01 |
| Stage2-vs-Stage3 |
4.141000E-03 |
| Stage2-vs-Stage4 |
4.433800E-02 |
| Stage3-vs-Stage4 |
8.164000E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.296420E-01 |
| Normal-vs-AfricanAmerican |
2.850200E-02 |
| Normal-vs-Asian |
1.850980E-01 |
| Caucasian-vs-AfricanAmerican |
9.847900E-02 |
| Caucasian-vs-Asian |
8.968000E-01 |
| AfricanAmerican-vs-Asian |
2.009400E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.247500E-02 |
| Normal-vs-Female |
7.720500E-02 |
| Male-vs-Female |
8.614400E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.117400E-01 |
| Normal-vs-Age(41-60Yrs) |
2.784200E-02 |
| Normal-vs-Age(61-80Yrs) |
3.536500E-02 |
| Normal-vs-Age(81-100Yrs) |
8.855000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.094020E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.961800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.303800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.842600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.728300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.797900E-02 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.738800E-01 |
| Classical-VS-Follicular |
6.829600E-04 |
| Classical-VS-Other |
1.438200E-02 |
| Classical-VS-Normal |
1.390170E-01 |
| Tall-VS-Follicular |
3.515800E-02 |
| Tall-VS-Other |
6.343500E-02 |
| Tall-VS-Normal |
1.851160E-01 |
| Follicular-VS-Other |
8.936000E-01 |
| Follicular-VS-Normal |
7.279800E-03 |
| Other-VS-Normal |
8.759700E-03 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.668000E-02 |
| Normal-vs-N1 |
4.710200E-02 |
| N0-vs-N1 |
5.926800E-01 |
|
|
